Inogen, Inc. (INGN)

Market Cap	174.23M
Revenue (ttm)	343.47M
Net Income (ttm)	-26.05M
Shares Out	26.89M
EPS (ttm)	-1.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	651,610
Open	6.03
Previous Close	5.87
Day's Range	6.00 - 6.80
52-Week Range	5.70 - 13.33
Beta	1.72
Analysts	Strong Buy
Price Target	11.00 (+70.02%)
Earnings Date	Aug 7, 2025

About BPMC

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 14, 2014
• Employees: 766
• Stock Exchange: NASDAQ
• Ticker Symbol: INGN
• Website: https://www.inogen.com

Financial Performance

In 2024, Inogen's revenue was $335.71 million, an increase of 6.35% compared to the previous year's $315.66 million. Losses were -$35.89 million, -64.97% less than in 2023.

Analyst Summary

According to 3 analysts, the average rating for INGN stock is "Strong Buy." The 12-month stock price target is $11.0, which is an increase of 70.02% from the latest price.

Price Target

$11.0

(70.02% upside)

Analyst Consensus: Strong Buy